JO
BBNX

John Overdeck’s Beta Bionics BBNX Stock Holding History

John Overdeck’s Portfolio BBNX Stock Details BBNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-65,495
Closed -$656K – 5531
2026
Q1 		$656K Sell
65,495
-345,108
-84% -$5.1M ﹤0.01% 3542
2025
Q4 		$12.5M Buy
410,603
+246,839
+151% +$6.59M 0.02% 981
2025
Q3 		$3.25M Buy
163,764
+142,468
+669% +$2.5M ﹤0.01% 1793
2025
Q2 		$310K Buy
21,296
+545
+3% +$7.71K ﹤0.01% 2780
2025
Q1 		$254K Buy
+20,751
New +$387K ﹤0.01% 2779

Other funds holding BBNX

EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCV
Sands Capital Ventures Arlington, Virginia $614M AUM 19.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

John Overdeck's BBNX Position: Q2 2026 in Review

John Overdeck sold out of Beta Bionics (BBNX) in Q2 2026, closing a stake of 65,495 shares — an estimated $656K sold.

John Overdeck first reported a position in BBNX in Q1 2025 and held it in 5 quarters. The position peaked at $12.5M in Q4 2025. 133 funds tracked by Wall St. Rank hold BBNX as of Q2 2026.

  • John Overdeck reported no remaining Beta Bionics position as of Q2 2026 after selling out during the quarter.
  • John Overdeck sold 65,495 Beta Bionics shares in Q2 2026, an estimated $656K.
  • John Overdeck first reported a position in Beta Bionics in Q1 2025 and held it in 5 quarters.
  • John Overdeck's Beta Bionics position peaked at $12.5M in Q4 2025.
  • 133 funds tracked by Wall St. Rank held Beta Bionics as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.